Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence

The advent of second-generation androgen receptor axis-targeted agents (ARATs) has revolutionized the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). Biochemical recurrence-free survival (BRFS) was used to compare the efficacy of each ARAT. This multicenter retrospective study inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakane, Keita, Watanabe, Hiromitsu, Naiki, Taku, Takahara, Kiyoshi, Yasui, Takahiro, Miyake, Hideaki, Shiroki, Ryoichi, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178034/
https://www.ncbi.nlm.nih.gov/pubmed/37175052
http://dx.doi.org/10.3390/diagnostics13091661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178034/
https://www.ncbi.nlm.nih.gov/pubmed/37175052
http://dx.doi.org/10.3390/diagnostics13091661

Ejemplares similares